Find out about our research and research partners
Edinburgh Clinical Research Facility
Deep & Frequent Phenotyping Study (DFP)
The DFP study tracks biological and cognitive markers of Alzheimer's disease across time to find the best combination to detect disease change.
DPUK Harmonisation Study
The DPUK Harmonisation Study seeks to refine and calibrate imaging across a network of PET-MR scanners in the UK
Biogen EMBARK Study
The Biogen EMBARK Trial is a phase III clinical drug trial to evaluate safety and tolerability of aducanumab in participants with Alzheimer's disease who had previously participated in the earlier aducanumab studies.
CHARIOT PRO Substudy
The CHARIOT PRO substudy investigated brain amyloid as a biomarker of cognitive impairment due to Alzheimer's disease.
The SPeAK Study compares performance on memory and thinking tasks between a computerised administrator and a real person administrator over the telephone.